Delivery Order SPE2DB22D3004-SPE2DB25FRC68

Award Date 6/17/25
Potential Completion Date 6/18/25
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Duloxetine HCL DR 60 MG capsules, with a ceiling value of $4,443.90 and a period of performance through April 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Duloxetine Hydrochloride delayed-release capsules. The contract has a ceiling value of $6,174.99 and an ultimate completion date of September 18, 2024. It is a firm fixed-price contract for the delivery of this prescription medication. The contract is not set aside for any specific business category. AmerisourceBergen,...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) as a Firm Fixed Price Delivery Order for the supply of Duloxetine HCl DR 40 mg capsules. The award, valued at $1,483.26, has an ultimate completion date of May 14, 2025 and is not set aside for any particular type of business. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is a delivery order issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,215.82 firm fixed-price contract is for the delivery of 4,566,516,150 units of Duloxetine HCL DR 40 MG capsules. The contract has an ultimate completion date of November 22, 2024 and was awarded on November 21, 2024. No set-aside designation was used for this award....
This contract award is for the delivery of 30-count bottles of 40mg duloxetine hydrochloride delayed-release capsules to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,075.68 and an ultimate completion date of June 12, 2025. It is a firm fixed-price delivery order contract awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set aside and was competed openly....
This is a delivery order issued under a larger Indefinite Delivery Contract (IDC) by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $1,054.38 delivery order is for the supply of Duloxetine HCL DR 20 MG capsules. Amerisourcebergen, a major pharmaceutical distributor, provides a wide range of medical products and supplies to support military treatment facilities, veterans' hospitals, and other federal healthcare programs. The IDC...
This federal contract award, with ID SPE2DB22D3501|SPE2DB25FVQ42, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,414.79 firm fixed-price delivery order is for the supply of 4,568,204,795 units of Duloxetine HCL DR 30 mg capsules. The contract has an ultimate completion date of May 12, 2025 and was awarded on May 9, 2025. This award is not designated as a set-aside contract....
This federal contract award is for the delivery of Duloxetine HCL DR 60 MG capsules to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $5,310.82 and is a firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of October 10, 2024 and was awarded on October 9, 2024. It is not designated as a set-aside contract. AmerisourceBergen, through its extensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a large pharmaceutical distributor. The contract, valued at $17,345.67, is a delivery order to provide 4565427084 - Duloxetine HCL DR 60 MG capsules to the DLA. The contract has an ultimate completion date of August 13, 2024 and was awarded on August 12, 2024. This contract is not designated as a set-aside and is a firm fixed price contract. Amerisourcebergen, through its Corporate Office...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract (SPE2DB20D1102|SPE2DB24FC6GH) by the Defense Logistics Agency (DLA) Troop Support Medical to provide 4,564,256,178 units of the prescription medication Duloxetine HCL DR 30 mg capsules. The $1,680.45 award has an ultimate completion date of April 15, 2024. This delivery order falls under Amerisourcebergen's $999,999,999.00 indefinite delivery contract with DLA, which...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FRC68
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Duloxetine HCl DR 40 mg capsules. The contract has a ceiling value of $1,022.54 and a performance period extending through June 18, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

Generated 9/16/25, 10:01 AM